Cellus is betting that reshaping the terrain around a tumor -- not just going after the tumor itself -- can flip the switch ...

After Eli Lilly, Pfizer, and MSD (Merck & Co. in the U.S. and Canada) walked away from CETP inhibition, Korean pharma Chong ...

Fabry disease is a rare, inherited disorder caused by a mutation in the GLA gene on the X chromosome. This mutation leads to ...

The influenza pandemic advisory was lifted on Friday. However, due to the increase in Covid-19 infections in neighboring ...

Celltrion’s oncology biosimilars are rapidly solidifying their market dominance in Japan, one of Asia’s largest ...

The medical community emphasized the need for internal integration to resolve the government-doctor conflict.“It has been 10 ...

More than a decade after Korea’s National Health Insurance Service (NHIS) filed suit against major tobacco companies over the ...

The Korean Blood Disease and Cancer Association (KBDCA) represented Korea at the Global Myeloma Action Network (GMAN) 2025 ...

A research team at Chung-Ang University Hospital will develop a novel artificial intelligence (AI) algorithm aimed at ...

STGEN Bio, the biopharmaceutical contract manufacturing organization (CMO) under Dong-A Socio Group, said Friday it signed a ...

About 28 million doses of flu vaccine, including the first nasal spray flu vaccine to be distributed in Korea, FluMist Intranasal Spray, will likely be approved for national distribution this year.The ...

Belgium-based UCB's novel psoriasis therapy, Bimzelx (ingredient: bimekizumab), has officially entered Korea's competitive plaque psoriasis market with national health insurance coverage, positioning ...